APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biotechnology Contract Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biotechnology Contract Manufacturing Market Outlook and Growth Opportunities 2026

2 May 2026199 pages

Choose your research edition.

Industry ResearchBiotechnology Contract Manufacturing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Biotechnology Contract Manufacturing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biotechnology Contract Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biotechnology Contract Manufacturing Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Biotechnology Contract Manufacturing Market Analysis and Forecast 2026-2032246 pages · $4,950 USD

Market perspective

The global Biotechnology Contract Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biotechnology Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biotechnology Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biotechnology Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biotechnology Contract Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biotechnology Contract Manufacturing market include Lonza, Thermo Fisher Scientific, Inc., Catalent, Inc., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Holding Corporation, AbbVie, Inc. and Eurofins Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biotechnology Contract Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biotechnology Contract Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biotechnology Contract Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biotechnology Contract Manufacturing market.

Biotechnology Contract Manufacturing Segment by Company

Lonza

Thermo Fisher Scientific, Inc.

Catalent, Inc.

Samsung Biologics

WuXi Biologics

Boehringer Ingelheim International GmbH

FUJIFILM Holding Corporation

AbbVie, Inc.

Eurofins Scientific

AGC, Inc.

Merck KgaA

Biotechnology Contract Manufacturing Segment by Type

Biologic Drug Substance Manufacturing

Biologic Drug Product Manufacturing

Biotechnology Contract Manufacturing Segment by Application

Monoclonal Antibodies

Cell Therapy & Gene Therapy

Antibody-Drug Conjugates (ADCs)

Vaccines

Therapeutic Peptides & Proteins

Others

Biotechnology Contract Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biotechnology Contract Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biotechnology Contract Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Biotechnology Contract Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biotechnology Contract Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biotechnology Contract Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Biotechnology Contract Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biotechnology Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biotechnology Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biotechnology Contract Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biotechnology Contract Manufacturing industry.

Chapter 3: Detailed analysis of Biotechnology Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biotechnology Contract Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biotechnology Contract Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biotechnology Contract Manufacturing Industry Trends Table 2. Biotechnology Contract Manufacturing Industry Drivers Table 3. Biotechnology Contract Manufacturing Industry Opportunities and Challenges Table 4. Biotechnology Contract Manufacturing Industry Restraints Table 5. Global Biotechnology Contract Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biotechnology Contract Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Biotechnology Contract Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biotechnology Contract Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Biotechnology Contract Manufacturing Company, Product Type & Application Table 10. Global Biotechnology Contract Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biotechnology Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Biologic Drug Substance Manufacturing Table 15. Significant Companies of Biologic Drug Product Manufacturing Table 16. Global Biotechnology Contract Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biotechnology Contract Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biotechnology Contract Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biotechnology Contract Manufacturing Sales Value Share by Type (2021-2026) Table 20. Global Biotechnology Contract Manufacturing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Monoclonal Antibodies Table 22. Significant Companies of Cell Therapy & Gene Therapy Table 23. Significant Companies of Antibody-Drug Conjugates (ADCs) Table 24. Significant Companies of Vaccines Table 25. Significant Companies of Therapeutic Peptides & Proteins Table 26. Significant Companies of Others Table 27. Global Biotechnology Contract Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biotechnology Contract Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Biotechnology Contract Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Biotechnology Contract Manufacturing Sales Value Share by Application (2021-2026) Table 31. Global Biotechnology Contract Manufacturing Sales Value Share by Application (2027-2032) Table 32. Global Biotechnology Contract Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Biotechnology Contract Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Biotechnology Contract Manufacturing Sales Value Share by Region (2021-2026) Table 35. Global Biotechnology Contract Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Biotechnology Contract Manufacturing Sales Value Share by Region (2027-2032) Table 37. Global Biotechnology Contract Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Biotechnology Contract Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Biotechnology Contract Manufacturing Sales Value Market Share by Country (2021-2026) Table 40. Global Biotechnology Contract Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Biotechnology Contract Manufacturing Sales Value Market Share by Country (2027-2032) Table 42. Lonza Company Information Table 43. Lonza Business Overview Table 44. Lonza Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Lonza Biotechnology Contract Manufacturing Product Portfolio Table 46. Lonza Recent Development Table 47. Thermo Fisher Scientific, Inc. Company Information Table 48. Thermo Fisher Scientific, Inc. Business Overview Table 49. Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 51. Thermo Fisher Scientific, Inc. Recent Development Table 52. Catalent, Inc. Company Information Table 53. Catalent, Inc. Business Overview Table 54. Catalent, Inc. Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Catalent, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 56. Catalent, Inc. Recent Development Table 57. Samsung Biologics Company Information Table 58. Samsung Biologics Business Overview Table 59. Samsung Biologics Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Samsung Biologics Biotechnology Contract Manufacturing Product Portfolio Table 61. Samsung Biologics Recent Development Table 62. WuXi Biologics Company Information Table 63. WuXi Biologics Business Overview Table 64. WuXi Biologics Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. WuXi Biologics Biotechnology Contract Manufacturing Product Portfolio Table 66. WuXi Biologics Recent Development Table 67. Boehringer Ingelheim International GmbH Company Information Table 68. Boehringer Ingelheim International GmbH Business Overview Table 69. Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Product Portfolio Table 71. Boehringer Ingelheim International GmbH Recent Development Table 72. FUJIFILM Holding Corporation Company Information Table 73. FUJIFILM Holding Corporation Business Overview Table 74. FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Product Portfolio Table 76. FUJIFILM Holding Corporation Recent Development Table 77. AbbVie, Inc. Company Information Table 78. AbbVie, Inc. Business Overview Table 79. AbbVie, Inc. Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. AbbVie, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 81. AbbVie, Inc. Recent Development Table 82. Eurofins Scientific Company Information Table 83. Eurofins Scientific Business Overview Table 84. Eurofins Scientific Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Eurofins Scientific Biotechnology Contract Manufacturing Product Portfolio Table 86. Eurofins Scientific Recent Development Table 87. AGC, Inc. Company Information Table 88. AGC, Inc. Business Overview Table 89. AGC, Inc. Biotechnology Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. AGC, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 91. AGC, Inc. Recent Development Table 92. Merck KgaA Company Information Table 93. Merck KgaA Business Overview Table 94. Merck KgaA Biotechnology Contract Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Merck KgaA Biotechnology Contract Manufacturing Product Portfolio Table 96. Merck KgaA Recent Development Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Biotechnology Contract Manufacturing Product Image Figure 2. Global Biotechnology Contract Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biotechnology Contract Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Biotechnology Contract Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Biologic Drug Substance Manufacturing Image Figure 8. Biologic Drug Product Manufacturing Image Figure 9. Global Biotechnology Contract Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biotechnology Contract Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biotechnology Contract Manufacturing Sales Value Share by Type (2021-2032) Figure 12. Monoclonal Antibodies Image Figure 13. Cell Therapy & Gene Therapy Image Figure 14. Antibody-Drug Conjugates (ADCs) Image Figure 15. Vaccines Image Figure 16. Therapeutic Peptides & Proteins Image Figure 17. Others Image Figure 18. Global Biotechnology Contract Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biotechnology Contract Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Biotechnology Contract Manufacturing Sales Value Share by Application (2021-2032) Figure 21. Global Biotechnology Contract Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Biotechnology Contract Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Biotechnology Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 24. North America Biotechnology Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Biotechnology Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Biotechnology Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Biotechnology Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Biotechnology Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Biotechnology Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 30. South America Biotechnology Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Biotechnology Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Biotechnology Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Biologic Drug Substance Manufacturing
  • Biologic Drug Product Manufacturing
Applications
  • Monoclonal Antibodies
  • Cell Therapy & Gene Therapy
  • Antibody-Drug Conjugates (ADCs)
  • Vaccines
  • Therapeutic Peptides & Proteins
  • Others
Companies covered
  • Lonza
  • Thermo Fisher Scientific, Inc.
  • Catalent, Inc.
  • Samsung Biologics
  • WuXi Biologics
  • Boehringer Ingelheim International GmbH
  • FUJIFILM Holding Corporation
  • AbbVie, Inc.
  • Eurofins Scientific
  • AGC, Inc.
  • Merck KgaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biotechnology Contract Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biotechnology Contract Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biotechnology Contract Manufacturing Market Dynamics
  1. 2.1 Biotechnology Contract Manufacturing Industry Trends
  2. 2.2 Biotechnology Contract Manufacturing Industry Drivers
  3. 2.3 Biotechnology Contract Manufacturing Industry Opportunities and Challenges
  4. 2.4 Biotechnology Contract Manufacturing Industry Restraints
3 Biotechnology Contract Manufacturing Market by Company
  1. 3.1 Global Biotechnology Contract Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Biotechnology Contract Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Biotechnology Contract Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Biotechnology Contract Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Biotechnology Contract Manufacturing Company Product Type and Application
  6. 3.6 Global Biotechnology Contract Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biotechnology Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biotechnology Contract Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biotechnology Contract Manufacturing Market by Type
  1. 4.1 Biotechnology Contract Manufacturing Type Introduction
  2. 4.1.1 Biologic Drug Substance Manufacturing
  3. 4.1.2 Biologic Drug Product Manufacturing
  4. 4.2 Global Biotechnology Contract Manufacturing Sales Value by Type
  5. 4.2.1 Global Biotechnology Contract Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biotechnology Contract Manufacturing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biotechnology Contract Manufacturing Sales Value Share by Type (2021-2032)
5 Biotechnology Contract Manufacturing Market by Application
  1. 5.1 Biotechnology Contract Manufacturing Application Introduction
  2. 5.1.1 Monoclonal Antibodies
  3. 5.1.2 Cell Therapy & Gene Therapy
  4. 5.1.3 Antibody-Drug Conjugates (ADCs)
  5. 5.1.4 Vaccines
  6. 5.1.5 Therapeutic Peptides & Proteins
  7. 5.1.6 Others
  8. 5.2 Global Biotechnology Contract Manufacturing Sales Value by Application
  9. 5.2.1 Global Biotechnology Contract Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Biotechnology Contract Manufacturing Sales Value by Application (2021-2032)
  11. 5.2.3 Global Biotechnology Contract Manufacturing Sales Value Share by Application (2021-2032)
6 Biotechnology Contract Manufacturing Regional Value Analysis
  1. 6.1 Global Biotechnology Contract Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biotechnology Contract Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biotechnology Contract Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biotechnology Contract Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biotechnology Contract Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Biotechnology Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biotechnology Contract Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Biotechnology Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biotechnology Contract Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biotechnology Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biotechnology Contract Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Biotechnology Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biotechnology Contract Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biotechnology Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Biotechnology Contract Manufacturing Country-level Value Analysis
  1. 7.1 Global Biotechnology Contract Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biotechnology Contract Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biotechnology Contract Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biotechnology Contract Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biotechnology Contract Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biotechnology Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biotechnology Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Biotechnology Contract Manufacturing Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 Thermo Fisher Scientific, Inc.
  8. 8.2.1 Thermo Fisher Scientific, Inc. Company Information
  9. 8.2.2 Thermo Fisher Scientific, Inc. Business Overview
  10. 8.2.3 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific, Inc. Recent Developments
  13. 8.3 Catalent, Inc.
  14. 8.3.1 Catalent, Inc. Company Information
  15. 8.3.2 Catalent, Inc. Business Overview
  16. 8.3.3 Catalent, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Catalent, Inc. Biotechnology Contract Manufacturing Product Portfolio
  18. 8.3.5 Catalent, Inc. Recent Developments
  19. 8.4 Samsung Biologics
  20. 8.4.1 Samsung Biologics Company Information
  21. 8.4.2 Samsung Biologics Business Overview
  22. 8.4.3 Samsung Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Samsung Biologics Biotechnology Contract Manufacturing Product Portfolio
  24. 8.4.5 Samsung Biologics Recent Developments
  25. 8.5 WuXi Biologics
  26. 8.5.1 WuXi Biologics Company Information
  27. 8.5.2 WuXi Biologics Business Overview
  28. 8.5.3 WuXi Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi Biologics Biotechnology Contract Manufacturing Product Portfolio
  30. 8.5.5 WuXi Biologics Recent Developments
  31. 8.6 Boehringer Ingelheim International GmbH
  32. 8.6.1 Boehringer Ingelheim International GmbH Company Information
  33. 8.6.2 Boehringer Ingelheim International GmbH Business Overview
  34. 8.6.3 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Product Portfolio
  36. 8.6.5 Boehringer Ingelheim International GmbH Recent Developments
  37. 8.7 FUJIFILM Holding Corporation
  38. 8.7.1 FUJIFILM Holding Corporation Company Information
  39. 8.7.2 FUJIFILM Holding Corporation Business Overview
  40. 8.7.3 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Product Portfolio
  42. 8.7.5 FUJIFILM Holding Corporation Recent Developments
  43. 8.8 AbbVie, Inc.
  44. 8.8.1 AbbVie, Inc. Company Information
  45. 8.8.2 AbbVie, Inc. Business Overview
  46. 8.8.3 AbbVie, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie, Inc. Biotechnology Contract Manufacturing Product Portfolio
  48. 8.8.5 AbbVie, Inc. Recent Developments
  49. 8.9 Eurofins Scientific
  50. 8.9.1 Eurofins Scientific Company Information
  51. 8.9.2 Eurofins Scientific Business Overview
  52. 8.9.3 Eurofins Scientific Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eurofins Scientific Biotechnology Contract Manufacturing Product Portfolio
  54. 8.9.5 Eurofins Scientific Recent Developments
  55. 8.10 AGC, Inc.
  56. 8.10.1 AGC, Inc. Company Information
  57. 8.10.2 AGC, Inc. Business Overview
  58. 8.10.3 AGC, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AGC, Inc. Biotechnology Contract Manufacturing Product Portfolio
  60. 8.10.5 AGC, Inc. Recent Developments
  61. 8.11 Merck KgaA
  62. 8.11.1 Merck KgaA Company Information
  63. 8.11.2 Merck KgaA Business Overview
  64. 8.11.3 Merck KgaA Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Merck KgaA Biotechnology Contract Manufacturing Product Portfolio
  66. 8.11.5 Merck KgaA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst